Cargando…
A Tripeptide Diapin Effectively Lowers Blood Glucose Levels in Male Type 2 Diabetes Mice by Increasing Blood Levels of Insulin and GLP-1
The prevalence of type 2 diabetes (T2D) is rapidly increasing worldwide. Effective therapies, such as insulin and Glucagon-like peptide-1 (GLP-1), require injections, which are costly and result in less patient compliance. Here, we report the identification of a tripeptide with significant potential...
Autores principales: | Zhang, Jifeng, Xue, Changyong, Zhu, Tianqing, Vivekanandan, Anuradha, Pennathur, Subramaniam, Ma, Zhongmin Alex, Chen, Y. Eugene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873933/ https://www.ncbi.nlm.nih.gov/pubmed/24386218 http://dx.doi.org/10.1371/journal.pone.0083509 |
Ejemplares similares
-
Tripeptide analysis of protein structures
por: Anishetty, Sharmila, et al.
Publicado: (2002) -
Blood glucose and insulin levels in patients with peripheral vestibular disease
por: Paula Serra, Ana, et al.
Publicado: (2015) -
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019) -
Effects of Vegetables Consumption Before Carbohydrates on Blood Glucose and GLP-1 Levels Among Diabetic Patients in Indonesia
por: Indarto, Dono, et al.
Publicado: (2022) -
GLP-1 receptor agonists modulate blood glucose levels in T2DM by affecting Faecalibacterium prausnitzii abundance in the intestine
por: Liang, Lei, et al.
Publicado: (2023)